Literature DB >> 11577486

Cervical cancer: prevention, diagnosis, and therapeutics.

M F Janicek1, H E Averette.   

Abstract

Cervical cancer is a leading cause of cancer deaths in women worldwide. Because of its association with human papilloma virus infection, as well as the ability to screen for premalignant stages of the disease, it is now largely a preventable disease. This article describes the molecular basis for cervical cancer, and presents a clinical overview of current treatment approaches and technological advances, emphasizing the unique aspects of this viral disease as it relates to the immune system and vaccination or other immunotherapeutic strategies.

Entities:  

Mesh:

Year:  2001        PMID: 11577486     DOI: 10.3322/canjclin.51.2.92

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  26 in total

1.  Fluorescence spectroscopy: a new approach in cervical cancer.

Authors:  Kiran Pandey; Asima Pradhan; Asha Agarwal; Ajay Bhagoliwal; Nidhi Agarwal
Journal:  J Obstet Gynaecol India       Date:  2012-10-23

2.  Effects of DCK knockdown on proliferation, apoptosis and tumorigenicity in vivo of cervical cancer HeLa cells.

Authors:  Q-Y Shang; C-S Wu; H-R Gao
Journal:  Cancer Gene Ther       Date:  2017-08-18       Impact factor: 5.987

3.  Terahertz time-domain spectroscopy combined with fuzzy rule-building expert system and fuzzy optimal associative memory applied to diagnosis of cervical carcinoma.

Authors:  Na Qi; Zhuoyong Zhang; Yuhong Xiang; Yuping Yang; Peter de B Harrington
Journal:  Med Oncol       Date:  2014-11-30       Impact factor: 3.064

4.  Lupeol induces S-phase arrest and mitochondria-mediated apoptosis in cervical cancer cells.

Authors:  Nupoor Prasad; Akash Sabarwal; Umesh C S Yadav; Rana P Singh
Journal:  J Biosci       Date:  2018-06       Impact factor: 1.826

5.  Matrix metalloproteinase-9 is a prognostic marker for patients with cervical cancer.

Authors:  Yi Li; Tao Wu; Beilei Zhang; Yuanqing Yao; Guowu Yin
Journal:  Med Oncol       Date:  2012-06-30       Impact factor: 3.064

6.  A Shandon PapSpin liquid-based gynecological test: A split-sample and direct-to-vial test with histology follow-up study.

Authors:  J Rimiene; J Petronyte; Z Gudleviciene; Giedre Smailyte; Ingrida Krasauskaite; A Laurinavicius
Journal:  Cytojournal       Date:  2010-03-20       Impact factor: 2.091

7.  A phase II trial of erlotinib in recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.

Authors:  Russell J Schilder; Michael W Sill; Yi-Chun Lee; Robert Mannel
Journal:  Int J Gynecol Cancer       Date:  2009-07       Impact factor: 3.437

8.  Human papillomavirus, cervical cancer and women's knowledge.

Authors:  Azadeh Stark; Lucie Gregoire; Rebecca Pilarski; Allison Zarbo; Arthur Gaba; Wayne D Lancaster
Journal:  Cancer Detect Prev       Date:  2008-04-10

9.  Demethoxycurcumin Inhibits In Vivo Growth of Xenograft Tumors of Human Cervical Cancer Cells.

Authors:  Hung-Yi Chen; Shu-Fen Peng; Fu-Shin Chueh; Jin-Cherng Lien; Yu-Cheng Chou; Wen-Wen Huang; Yi-Ping Huang; Jye-Yu Huang; Jung-Yu Kuo; Wan-Ni Huang; Shou-Yi Sheng; Hao-Yun Tung
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

10.  Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer.

Authors:  Yajuan Wang; Lejing Zhang; Bin Wang; Yuanfang Cheng
Journal:  Biomed Res Int       Date:  2021-07-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.